SAN DIEGO, Aug. 28, 2012 /PRNewswire/ -- ADVENTRX
Pharmaceuticals, Inc. (NYSE MKT: ANX) today announced that the
Company's Chief Executive Officer, Brian M.
Culley, will present at the Rodman & Renshaw Annual
Global Investment Conference on Monday,
September 10, 2012 at 2:25 p.m.
Eastern time, in the Starlight Center Salon at The Waldorf
Astoria hotel in New York
City.
Interested parties can access a live audio webcast and slide
presentation on the ADVENTRX Pharmaceuticals web site at
www.adventrx.com. An archived presentation will be available on the
web site for 30 days.
About ADVENTRX Pharmaceuticals
ADVENTRX Pharmaceuticals is a biopharmaceutical company
developing proprietary product candidates to treat various diseases
and conditions. The Company's lead product candidate, ANX-188, has
potential to reduce ischemic tissue injury and end-organ damage by
restoring microvascular function which is compromised in a wide
range of serious and life-threatening diseases and
conditions. The Company initially is developing ANX-188 as a
treatment for complications arising from sickle cell disease. More
information can be found on the Company's web site at
www.adventrx.com.
(Logo:
http://photos.prnewswire.com/prnh/20120612/LA22456LOGO-a)
SOURCE ADVENTRX Pharmaceuticals, Inc.